Success of EBUS service cuts patient waiting times
Central Manchester University Hospitals has become one of just a
handful of hospitals in the UK to offer the EBUS diagnostic
Endobronchial ultrasound guided fine needle aspiration cytology
(EBUS-FNAC) offers cancer and non-cancer respiratory patients,
particularly those suspected of having tuberculosis, an optimal,
prompt, high quality, minimally invasive and cost-effective
CMFT began offering the service in October, along with Rapid
On-Site Evaluation, or ROSE, and early results for the service have
been very positive, with more than 97 per cent of procedures
EBUS-FNAC was recommended by the National Institute for Health
and Clinical Excellence (NICE) for diagnosis and staging of lung
cancer through sampling of mediastinal lymph nodes, in 2011.
When combined with on-site adequacy assessment and provisional
diagnosis by a specialist cytopathologist, EBUS-FNAC offers rapid
diagnosis and the ability to triage material for microbiology, flow
cytometry, diagnostic immunocytochemistry and molecular testing to
facilitate personalised therapy.
CMFT is the only hospital trust in the Greater Manchester and
Cheshire area to provide EBUS with consultant-driven ROSE and
The introduction of the service has already cut patient waiting
times and has been extended for use with non-cancer cases. Demand
for the service continues to increase.
To find out more about the EBUS service contact our Respiratory or